Clinical Definition and Diagnostic Overview
Substance use disorders (SUD) occur when the repeated use of alcohol and/or other drugs significantly impairs a person’s health and results in an inability to meet major responsibilities at work, school, or home. SUD is considered a brain disorder that can be mild, moderate, or severe, with the most severe form categorized as addiction.
The Three-Stage Cycle of Addiction:
Binge/Intoxication: Consuming the substance and experiencing rewarding effects.
Withdrawal/Negative Affect: Experiencing a negative emotional or physical state in the absence of the substance.
Preoccupation/Anticipation: Seeking the substance again after a period of abstinence.
Neurobiology of SUD
Nurses must understand the brain regions involved to treat SUD as a physiological condition rather than a behavioral choice:
Basal Ganglia: Involved in forming habits and routine behaviors; reacts to substances with surges of dopamine, creating a reward circuit.
Extended Amygdala: Involved in the stress response and feelings of unease or anxiety that accompany withdrawal.
Prefrontal Cortex: Responsible for executive function and time management; in SUD, this area loses the ability to exert control over substance use.
Tolerance: Occurs when the brain adapts to the substance, requiring stronger or more frequent doses to achieve the same effect.
Nursing Assessment: Recognizing Cues
Assessment begins with laboratory testing to determine current usage and overall health status.
Priority Labs: Urine Drug Screen (UDS), Blood Alcohol Level (BAL), and for female clients, a pregnancy test (HCG).
Physiological Screens: CBC (checks for anemia/infection), BMP (electrolytes), LFT and Hepatitis panel (liver damage from alcohol or IV drug use), and pancreatic enzymes.
Substance History: Assess what substances are used, quantity, frequency, last use, and the route of administration (e.g., oral, snorting, or injection).
Prescription Drug Monitoring Program (PDMP): Providers use this electronic database to track controlled substance prescriptions and identify clients at risk for overdose.
Substance-Specific Clinical Cues & Emergencies
Substance
Intoxication Cues
Withdrawal/Overdose Risks
Alcohol (AUD)
Slurred speech, lack of coordination, unsteady gait, nystagmus, and impaired memory.
Delirium Tremens (DTs): A medical emergency starting 48–96 hours after the last drink. Symptoms include fever, tachycardia, hypertension, and hallucinations.
Opioids (OUD)
Euphoria followed by apathy, pupillary constriction (pinpoint pupils), and drowsiness.
Overdose Triad: Pinpoint pupils, respiratory depression, and decreased level of consciousness. Naloxone (Narcan) is the reversal agent.
Stimulants
Pharmacological Standards
Medication-Assisted Treatment (MAT): A holistic approach combining medication and behavioral therapy to improve outcomes.
For AUD: Naltrexone (blocks the "high"), Acamprosate (reduces cravings), and Disulfiram (causes unpleasant reaction if alcohol is consumed).
For OUD: Methadone (reaches receptors and reduces cravings), Buprenorphine (decreases withdrawal symptoms), and Naltrexone.
Withdrawal Management: Nurses use standardized scales like the CIWA-Ar (for alcohol) or COWS (for opioids) to determine the need for medication-triggered treatment.
Nutritional Support: Chronic alcohol use often requires Thiamine (B1) and folic acid supplementation to prevent Wernicke’s encephalopathy.
Evidence-Based Interventions
Motivational Interviewing (MI): A client-centered approach to enhance intrinsic motivation and explore ambivalence about change.
Harm Reduction: Focuses on meeting the client where they are to prevent overdose and reduce the transmission of infectious diseases (e.g., needle exchanges).
Relapse Prevention: Educating the client on their "Quit Date," removal of environmental triggers, and using distraction techniques.
Dual Diagnosis Care: Approximately half of people with a mental health disorder also have an SUD; treatments must address both simultaneously.
Ethics: The Impaired Nurse
Nurses have a legal and ethical responsibility to report colleagues suspected of SUD to protect client safety.
Signs of Impairment: Discrepancies in opioid counts, frequent trips to the bathroom, isolation from colleagues, and multiple medication errors.
Drug Diversion: Redirecting medication from a client for personal use or sale; this is a felony.
Alternative to Discipline: Programs like TPAPN in Texas allow impaired nurses to receive treatment and peer support to eventually return to safe practice.
Pedagogical Directives for the LLM Trainer
In CYOA Scenarios: If a client in alcohol withdrawal has a rising heart rate and BP, and the student chooses "Wait and see" instead of "Administering benzodiazepine per CIWA protocol," simulate a Withdrawal Seizure.
In Voice Sessions: If the student uses judgmental language (e.g., "Why can't you just stop drinking?"), have the client character respond with Denial or Aggression.
Critical Safety Check: During an opioid overdose scenario, force the student to recognize the Overdose Triad before they are allowed to select Naloxone as the intervention.
Motivation Goal: Require the student to identify the client's current Stage of Change. If they push a "Maintenance" intervention on a client in "Precontemplation," trigger a "Rapport Failure" outcome.
Would you like to move to the next skill: Neurocognitive Disorders (Delirium & Dementia)?